Cargando…
Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
Recent studies have demonstrated that splenic extramedullary hematopoiesis (EMH) is an important mechanism for the accumulation of myeloid-derived suppressor cells (MDSCs) in tumor tissues, and thus contributes to disease progression. Icaritin, a prenylflavonoid derivative from plants of the Epimedi...
Autores principales: | Tao, Huimin, Liu, Mingyu, Wang, Yuan, Luo, Shufeng, Xu, Yongquan, Ye, Bin, Zheng, Limin, Meng, Kun, Li, Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952329/ https://www.ncbi.nlm.nih.gov/pubmed/33717093 http://dx.doi.org/10.3389/fimmu.2021.609295 |
Ejemplares similares
-
Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival
por: Qin, Shu‐Kui, et al.
Publicado: (2020) -
VLA-1 Binding to Collagen IV Controls Effector T Cell Suppression by Myeloid-Derived Suppressor Cells in the Splenic Red Pulp
por: Eckert, Ina N., et al.
Publicado: (2021) -
First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers
por: Fan, Ying, et al.
Publicado: (2019) -
Generation of Myeloid Cells in Cancer: The Spleen Matters
por: Wu, Chong, et al.
Publicado: (2020) -
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)